Herpes Simplex Encephalitis Prognosis and Treatment

Mortality and General Outcomes

• The mortality rate of herpes simplex encephalitis has decreased to 20-30% with acyclovir treatment, but it exceeds 70% in untreated patients, according to the Journal of Infection guidelines 1

Prognostic Factors

• Delaying treatment for more than 2 days after hospital admission is the most important modifiable factor associated with poor prognosis, with a significant impact on patient outcomes 2, 1
• Delaying treatment for more than 48 hours significantly worsens the prognosis, highlighting the importance of prompt treatment initiation 2, 1

Treatment Duration and Monitoring

• The American College of Physicians recommends a treatment duration of 14-21 days, with PCR control at the end of treatment to ensure viral clearance 3, 1
• Treatment should be continued until PCR negativity is achieved, with weekly PCR monitoring, to prevent relapse 3, 1

Special Considerations

• Immunocompromised patients may require longer treatment durations to achieve viral clearance, and closer monitoring is necessary 4

Herpes Simplex Encephalitis Prognosis

Prognostic Factors

• The American College of Physicians recommends that the prognosis of herpes simplex encephalitis is determined by factors such as the timing of treatment initiation, patient age, and clinical condition at presentation, rather than viral load 5
• Starting treatment with acyclovir within the first 4 days of symptom onset reduces mortality from 28% to 8% 5
• Delaying treatment initiation by more than 2 days after hospital admission is independently associated with poor prognosis 6, 7, 8, 9
• Advanced age (≥30 years or older) is associated with poor outcomes 5
• A Glasgow coma score of less than 6 is associated with worse outcomes 5
• Treatment initiation within the first 6 hours of hospital admission is recommended 10
• The treatment duration should be planned for 14-21 days 5, 11, 10
• The prognosis assessment should be based on the patient's age, clinical condition at presentation (SAPS II, Glasgow coma score), and timing of treatment initiation 5